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Surface characteristicsThe area of implant osseointegration is of major importance, given the predicted signiﬁcant rise in the
number of orthopaedic procedures and an increasingly ageing population. Osseointegration is a complex
process involving a number of distinct mechanisms affected by the implant bulk properties and surface
characteristics. Our understanding and ability to modify these mechanisms through alterations in
implant design is continuously expanding. The following review considers the main aspects of material
and surface alterations in metal implants, and the extent of their subsequent inﬂuence on osseointegra-
tion. Clinically, osseointegration results in asymptomatic stable durable ﬁxation of orthopaedic implants.
The complexity of achieving this outcome through incorporation and balance of contributory factors is
highlighted through a clinical case report.
 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction revision [7], or late, resulting in the implant loosening. Currently,The value of the global orthopaedic implant market, including
joint replacements, spinal and trauma implants, was estimated at
over US$30.5 billion in 2012 [1]. In 2012, the UK National Joint
Registry recorded 86,488 primary total hip replacements (THRs)
and 9,678 revisions [2]. The long-term implantable joint replace-
ment hardware is broadly subdivided into cemented and unce-
mented, and of the primary THR operations, 43% were
uncemented and 20% hybrid [2]. Uncemented implants rely on
the process of osseointegration for their incorporation into the
bone and long-term survival. The term ‘‘osseointegration’’, derived
from the Latin words ‘‘os’’ (meaning bone) and ‘‘integrare’’ (mean-
ing make whole), was initially coined by Professor Per-Ingvar
Brånemark in the late 1950s, following the observation of bone
and titanium integration [3], secondary to the formation of a direct
interface between remodelled viable bone and the implant [4]. This
interface is expected to be free of any evidence of the inﬂammatory
response, and ﬁbrous or connective tissue formation [5]. Osseoin-
tegration was clinically deﬁned as ‘‘a process whereby clinically
asymptomatic rigid ﬁxation of alloplastic materials is achieved,
and maintained, in bone during functional loading’’ [6]. In essence,
implant osseointegration can be disrupted early, leading to the loss
of primary stability and early migration, likely necessitating earlyaseptic loosening is the most common cause of revision in hip
and knee arthroplasty, accounting for 40% and 32% of all cases,
respectively [2]. Speciﬁcally, early aseptic loosening is likely to
be related to the issues of material and implant design affecting
osseointegration. This emphasizes the need to optimize osseointe-
gration in order to reduce and ultimately avoid revisions.
The extent and success of osseointegration depend on the
biocompatibility of the implanted material. The concept of biocom-
patibility and its constitutive elements remain, to date, unclear [8].
Professor David Williams deﬁned biocompatibility as ‘‘the ability
of a material to perform with an appropriate host response in a
speciﬁc situation’’ [9]. Over the last 25 years, the ﬁelds of orthopae-
dics and tissue engineering have progressed from the replacement
and ﬁxation of damaged mechanical elements to the application of
regenerative medicine, including strategies to repair, replace and/
or restore cells and tissues lost or damaged as a result of destruc-
tive mechanisms. The paradigm of generating an organized and
functional tissue from expanded and appropriately stimulated
stem cells with a matrix scaffold remains an attractive subject of
intense research, although, to date, of limited commercial viability.
Consequently, the design of orthopaedic implantable materials
seeks to incorporate features capable of positively changing the
dynamics of bio-integration (enhancing and improving the quality
of host bone apposition to the implants). Biocompatibility was
subsequently redeﬁned as ‘‘the ability of a biomaterial to perform
its desired function with respect to a medical therapy, without(2014),
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or beneﬁciary of that therapy, but generating the most appropriate
beneﬁcial cellular or tissue response in that speciﬁc situation, and
optimising the clinically relevant performance of that therapy’’ [8].
In essence, an implant needs to be sufﬁciently inert to avoid an
undesirable systemic response (immune/inﬂammatory adverse
reactions) and retain the capacity ideally to stimulate
osseointegration.
Following implantation and attainment of primary stability
through mechanical press-ﬁt, the initial interface of an endosseous
orthopaedic implant will still retain spaces and deﬁciencies that
require native bone inﬁll through the process of osteogenesis in
order to achieve secondary stability. Post-implantation local bone
resorption due to pressure necrosis further compromises primary
stability. Secondary stability is achieved through the process of
osteogenesis, which occurs either by lamellar remodelling or by
woven bone deposition [10] on the surface of the host bone bed
and on the implant itself, known as distance and contact osteogen-
esis, respectively [11]. Contact osteogenesis is responsible for col-
onization of an implant surface by osteogenic cells followed by
the synthesis of extracellular bone matrix and subsequent apposi-
tional de novo bone formation [10], and is likely to be affected by
the material used in implant fabrication.
The exquisitely orchestrated spatio-temporal events that occur
during osteoblast development and bone formation are relevant to
the deposition of osteoid at the bone–implant interface [12]. Thus,
active proliferation takes place during the ﬁrst 10–12 days after
implantation, leading to the formation of cell focal nodules or mul-
tilayers. Subsequently, expression of extracellular matrix (ECM)
protein genes including type I collagen, ﬁbronectin and genes asso-
ciated with the osteoblast lineage such as alkaline phosphatase are
signiﬁcantly elevated. During the post-proliferative phase (12–
18 days), the ECM matrix matures and mineralization then occurs
(osteopontin, osteocalcin and bone sialoprotein observed). Exten-
sive mineralization at day 21 is associated with a reduction in alka-
line phosphatase (ALP) activity and, at around day 28, osteocalcin
and osteopontin activity falls. Hence, by 28 days most of the pro-
cesses related to the osteoblast proliferation, differentiation and
mineralization are thought to be complete. Interestingly, this
aligns with clinical practice of 4–6 weeks protected weight bearing
upon implant placement [12]. Any surface alterations should thus
aim to enhance and accelerate the above time frames, as well as
enhancing the strength of the implant–bone interface.
This review will focus on the mechanisms present at the bone–
implant interface, the interaction of the surface of the orthopaedic
device, speciﬁcally, the metal components and the modulation of
contact osteogenesis and osseointegration. The material character-
istics central to osseointegration and osteogenesis and thus
implant biocompatibility include:
(i). material properties – speciﬁcally, bulk properties (Section 2.1)
and surface properties (Section 2.2);
(ii). chemical (Section 2.2.1.1) and biochemical characteristics
(Section 2.2.1.2);
(iii). corrosion characteristics and wear debris release
(Section 2.2.2);
(iv). surface energy and wetting (Section 2.2.3);
(v). surface topography (Section 2.2.4).
2. Material properties
2.1. Bulk properties
The elemental makeup and structure of a material deﬁne its
bulk properties [13], such as the elastic modulus, hardness, frac-
ture toughness and wear resistance, which in turn are central toPlease cite this article in press as: Goriainov V et al. Bone and metal: An orth
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used in orthopaedic trauma and arthroplasty are metal in compo-
sition, due to their excellent mechanical strength [14]. The
implants are developed from tailored metallurgical processing
methods that deﬁne the bulk properties central to the implant–
host bone interaction, biocompatibility and osseointegration.
The most widely used metallic biomaterials are titanium (Ti)
and related alloys, cobalt (Co)–chromium (Cr) alloys and stainless
steel [8,15,16]. Ti and related alloys, as well as Co–Cr alloys, display
the greatest biocompatibility [8], aided by further alloying them
with different elements and subjecting the materials to different
processing routes to optimize toughness, ductility, tensile strength,
fatigue strength and surface hardness. Ti alloys have therefore
found widespread use as the gold standard in the parts of unce-
mented orthopaedic implants involved in osseointegration.
However, stiffness remains a signiﬁcant limitation of metals.
Wolff’s law of bone remodelling states that mechanical load (i.e.
strain) determines bone strength by affecting the bone architecture
[17], and is an essential stimulus in the natural process of fracture
healing and remodelling [18,19]. The femoral modulus of elasticity
is known to deteriorate by 2% each decade [20]. Thus, a signiﬁ-
cant mismatch between the elastic modulus of a load-bearing
implant and that of the bone deleteriously affects the load transfer
from the implant to the bone and within the bone, potentially lead-
ing to peri-implant bone resorption and implant loosening or bone
fracture [15,16,21]. This is a phenomenon known as stress shield-
ing. It has been noted in vitro and in vivo that osteogenic potential
is enhanced by high strains, alternating periods of strain loading
with rest, and high strain rates [22–24], with strain duration of
6 h suggested to be more effective than short load intervals in
the induction of bone morphogenetic protein 2 (BMP-2), runt-
related transcription factor 2 (Runx2) and osteocalcin gene expres-
sion in adipose-derived stem cells, thus modulating osteogenesis
[25]. Furthermore, changing strain induces extracellular ﬂuid ﬂow,
resulting in osteocyte cell membrane shear stresses [26] or gener-
ating streaming electric potentials [27]. Both mechanisms were
noted to enhance the recruitment and function of osteoblasts
in vitro [28,29]. Thus, stress shielding may result in peri-implant
strain protection, inhibiting these complex cellular mechanotrans-
duction mechanisms.
Ti alloys possess the most favourable speciﬁc strength (strength
to density ratio) and lowest modulus of elasticity [15,30] in the
group of metallic biomaterials, limiting the effect of stress shield-
ing. The mechanical strength of pure Ti can be enhanced through
modifying the microstructure of the material [31]. For example,
the addition of Al and V stabilizes the a- and b-phases, respec-
tively, creating a dual phase mechanically enhanced microstruc-
ture, which permits Ti–6Al–4V use in structural biomedical
applications [15,31]. To address the Young’s modulus being higher
than that of cortical bone and issues of Al and V release, a new
range of low modulus b-type Ti alloys was subsequently devel-
oped, incorporating a range of alloy constituents (e.g. Zr, Fe, Ta)
[16]. Nb, Zr, Mo and Ta have proved ideal for lowering the elastic
modulus while enhancing material strength [32,16]. Ti alloys exhi-
bit excellent corrosion resistance due to surface oxide ﬁlm forma-
tion [8,15]. However, the limitations of Ti alloys include poor shear
strength, low wear resistance and high notch sensitivity [16,33,34],
making them unsuitable for bearing surfaces.
The strength of pure Ti and its alloys can be enhanced by mod-
ifying the microstructure through grain reﬁnement. Indeed, nano-
grained b-Ti alloys in vitro are able to elicit greater attachment and
proliferation of ﬁbroblasts [35], pre-osteoblastic cells [36] and
stem cells [37]. This is likely a consequence of an alteration in
the surface topographical characteristics resulting from increased
nano-roughness, emphasizing the close interrelation between the
bulk and surface properties of the materials.opaedic perspective on osseointegration of metals. Acta Biomater (2014),
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relatively poor wear and corrosion resistance [15,34,38]. Thus,
despite its low cost, the poor wear and corrosion performance
and the issues around Ni release (discussed later) limit the use of
stainless steel to traumatology and osteosynthesis, where the
in vivo presence of the implants is typically temporary, or use as
long-term low-cost cemented implants [34]. Co–Cr alloys display
excellent wear and corrosion resistance as well as signiﬁcant fati-
gue strength as a consequence of their hardness, making these
materials ideal for bearing surfaces [15,34].
2.2. Surface properties
The implantation of an orthopaedic device results in exposure
of the surface to biological ﬂuids and surface modiﬁcation as a con-
sequence of host ions and cells, leading to further tissue response/
integration [39,40]. The process of surface colonization with
recruited cells is relatively non-speciﬁc, and thus the ability to
enhance host mesenchymal stem and progenitor cells is central
to the differentiation of the stem/progenitor pool into mature oste-
oblasts secreting osteoid [10,41]. Chemical composition, surface
energy, surface roughness and surface topography have all been
suggested as vital factors affecting skeletal cell behaviour [40].
2.2.1. Chemical and biochemical properties
The cell–material interaction is determined by the material’s
surface characteristics [42], typically deﬁned as the outermost
100 nm thick layer of an implant [43]. The surface chemical compo-
sition is representative of that of the bulkmaterial although the sur-
face will comprise highly reactive unsaturated bonds [44].Whilst Ti
and Co–Cr alloys demonstrate good biocompatibility, enhanced
osteoblast adhesion was observed on Ti6Al4V surfaces in vitro
[45]. Compared to Co–Cr, Ti alloys exhibit the ability for more rapid
integration, generating a signiﬁcantly stronger interface at
12 weeks in vivo [46]. Interestingly, Co–Cr alloys show a propensity
for cartilage and unmineralized osteoid formation at the interface.
Thus the ability to stimulate bone formation at the interface
appears key to the attainment of implant primary stability.
Oxidation of Ti surfaces (which can occur at atmospheric condi-
tions) and formation of a surface TiO2 layer through the process of
passivation is essential for improved osseointegration and a
dynamic interface [43,47]. Typically, TiO2 matches the topography
and roughness of the underlying substrate, is 2 nm thick and its
chemical properties are related to the surface preparation [44],
with a thicker TiO2 layer enhancing surface wettability and osteo-
blast ALP expression [48]. Spontaneous nucleation of apatite crys-
tals can occur on the surface of TiO2 [49], induced by OH groups in
the oxide layer on exposure to biological ﬂuids [50]. Ellingsen has
also shown that exposing TiO2 to calcium in vitro resulted in cal-
cium adsorption into the negatively charged oxide layer up to a
depth of 17 nm, resulting in selective protein binding [51],
although serum protein adsorption may have an inhibitory effect
on the capacity of TiO2 to induce nucleation.
2.2.1.1. Chemical modiﬁcations of metal surfaces. Ti and CoCr alloys
are biocompatible, but not bioactive [8,31]. One of the methods
of enhancing the anchorage of implants to bone is to induce bioac-
tivity of the constitutive material by manipulating the chemical
composition of the material [34,43]. Impregnation refers to inte-
grating a chemical or biochemical adjuvant within the bulk of a
material, e.g. alloys, where a true alteration of chemical composi-
tion is achieved [52]. Coating refers to the superﬁcial deposition
and bonding of a new chemical or biochemical adjuvant on the
core material [53], while the process of rendering the material
more bioactive is known as biofunctionalization [31].Please cite this article in press as: Goriainov V et al. Bone and metal: An orth
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phate, increases osteoconduction in vivo [54]. Plasma spray coating
with hydroxyapatite (HA) (Ca10(PO4)6(OH)2), remains one of the
most common methods of surface modiﬁcation of clinical implants
[34,55] due to the similarity of HA to the mineral phase of the bone
matrix [56], resulting in the induction of human mesenchymal
stem cell differentiation in vitro [52]. HA coating doubles the
strength of mechanical ﬁxation compared to uncoated Ti implants
at 4 weeks in vivo [57]. Calcium phosphate coating is thought to
result in bioactive implants interacting with bone [55,56] through
protein adsorption [10], while surface impregnation with Mg, S, P
and Ca has been reported to drive osseointegration and improve
bone-to-metal contact in vivo [58,59]. Strontium incorporation
into the TiO2 layer resulted in enhanced cell attachment, spreading
and osteoblast differentiation in vitro [60]. Surface modiﬁcation
with ﬂuoride resulted in an increase in the number of attached
cells in vitro [61], induction of osteoblast differentiation, higher
mineral density at the interface and improved pull-out force
in vivo [62,63], possibly by altering the surface chemistry and
nanotopography [52,54].
A reverse approach to stimulating osteoinduction has been to
inhibit bone resorption through targeted site-speciﬁc delivery of
bisphosphonates on implant surfaces. Bisphosphonate-modiﬁed
Ti implants were shown to result in signiﬁcantly enhanced early
new bone formation at the interface in vivo [64], likely, as a result
of inhibition of peri-implant bone resorption [65] even in the pres-
ence of particulate wear debris [66]. Prieto-Alhambra et al. have
shown a signiﬁcant implant survival increase in patients undergo-
ing clinical oral bisphosphonate therapy [65]. However, resorption
is a key component of the bone remodelling process, and there are
reports of ‘‘atypical’’ femoral, including periprosthetic, fractures
related to long-term bisphosphonate use [67].
2.2.1.2. Biochemical modiﬁcations of metal surfaces. The surface
chemical composition is important for protein adsorption and sub-
sequent cell adhesion [10,60] through transmembrane cell recep-
tors (integrins) [34], interacting via speciﬁc ECM amino acid
sequences, in particular Arg-Gly-Asp (RGD) [55,68]. Biofunctional-
ization of the surfaces with organic molecules has thus received
signiﬁcant interest under the wider umbrella of biochemical mod-
iﬁcation of titanium surfaces (BMTiS) [69]. These modiﬁcations
include linking of peptides, bone morphogenic proteins and
growth factors, ECM proteins and pharmacologically active mole-
cules. BMP is known to induce osteogenic differentiation [70],
and BMP/vascular endothelial growth factor (VEGF)-coated Ti
implants were demonstrated to enhance bone mineralization
in vivo [71]. Collagen and collagen + BMP coated implants demon-
strated superior osseointegration in vivo, although there was no
signiﬁcant difference between the coated groups [72]. In contrast,
the volume of in vivo bone deposition was reduced on BMP-2 func-
tionalized implant surfaces [73], possibly due to BMP-induced
osteoclast differentiation and activation [74]. In other studies, sup-
plementation of morselized bone allograft with BMP-2 increased
the rate of allograft resorption, reducing implant stability [57].
Although the systemic half-life of BMP was shown to be less than
20 min, this could be prolonged when delivered in association with
collagen [75] and heparin [76]. However, reports of host immune
responses against recombinant BMP [75] call into question the
clinical biocompatibility issue of BMP-2 peptide surface
modiﬁcations.
Xiao et al. described one of the earliest attempts to link
RGD-sequence-containing peptides to titanium surfaces [77], and
subsequently it was shown that RGD-modiﬁed Ti surfaces could
promote osteoblast attachment, compared to unmodiﬁed surfaces
in vitro [78]. It was suggested that increasing the concentration of
linked peptide sequences signiﬁcantly improved osteogenicopaedic perspective on osseointegration of metals. Acta Biomater (2014),
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modiﬁed Ti alloy surfaces enhanced osteoblast differentiation and
osteoid production, as well as osteoclast differentiation and thus,
potentially, bone remodelling in vitro [80]. In vivo studies have
also shown a likely beneﬁcial effect of Ti surface RGD modiﬁcation
on bone formation and ingrowth, reduction in ﬁbrous tissue forma-
tion, and improved implant ﬁxation [81,82].
Collagen exerts considerable inﬂuence on osteoblast behaviour
in vitro, enhancing differentiation and adhesion [83]; thus, colla-
gen coating of Ti and Co–Cr alloys appears attractive, although
in vitro experimental results are contradictory [84,85], whilst
in vivo studies indicate that there is no advantage on peri-implant
bone formation in pre-coating Ti surfaces with collagen over RGD-
containing peptides [72]. The enhancement of peri-implant bone
formation has been shown to be similar in collagen pre-coated sur-
faces and acid-etched rough Ti surfaces [86]. In order to prevent
implant colonization and formation of a bioﬁlm, immobilization
of antibiotics onto titanium surfaces was shown to be successful
in resisting infections in vitro [87].
2.2.2. Corrosion characteristics and wear debris release
Metals exposed to corrosive biological ﬂuids inevitably undergo
corrosion to some degree [88–90]. The breakdown of the protective
surface oxide layer subsequently results in exposure of the nascent
surface to corrosive attack and the potential release of metal ions
from an anode [90]. Four types of corrosion have been observed
in orthopaedic practice: (i) galvanic corrosion occurs when there
is an electrochemical potential difference between two different
metals, or between different areas of the same metal surface, when
immersed in a biological ﬂuid; (ii) pitting corrosion is caused by the
localized depassivation of the surface, or localized areas of different
potential due to the material microstructure, with autocatalytic
metal dissolution within the formed pits; (iii) crevice corrosion is
similar to pitting corrosion and occurs in conﬁned spaces, where
low oxygen tension, low pH and high chloride concentration lead
to destruction of the passivation layer; and (iv) in fretting corrosion,
the passivation layer is mechanically broken down due to micro-
motion between parts of an implant, exposing the nascent surface
to corrosive attack [91]. While crevice corrosion is more likely to
occur at the attachment site of metal parts, pitting and fretting cor-
rosion, as well as wear, affect the bearing surfaces.
The process of corrosion is dependent on the bulk and surface
material properties, as the elements of the bulk of the material
are released from the surface. This process is different from the
wear discussed below, which results in the production of particu-
late debris, although the processes of corrosion and wear are clo-
sely linked [92]. Experimental fretting wear accelerates the rate
of corrosion [93], including metal ions released not only as a con-
sequence of depassivation of the contacting surfaces, but also from
corrosion of the wear particles resulting in an increase in the metal
surface area in contact with corrosive body ﬂuids [93,94]. Clini-
cally, these ions are found locally and systemically [95]. Recently,
a degree of metal ion release has been attributed to corrosion at
the head-neck taper [96,97], indicating a combination of mechan-
ical fretting and crevice corrosion [96,98,99]. However, as metal
ions are known to be released from other devices not subjected
to mechanical friction (e.g. endovascular stents) [89], the electro-
chemical process of corrosion appears evident. Certain transition
metals, including V, Cr, Co and Ni, are known to cause systemic
effects of neurotoxicity, hepatotoxicity and nephrotoxicity [100].
In addition, V release can lead to haemolysis, anaemia, decreased
fertility, embryotoxicity and teratogenicity [101]. Al neurotoxicity
has been suggested to be secondary to the impairment of mito-
chondrial biogenetics [102]. Released metal ions can also activate
the immune system, either directly or by acting as haptens andPlease cite this article in press as: Goriainov V et al. Bone and metal: An orth
http://dx.doi.org/10.1016/j.actbio.2014.06.004forming complexes with native proteins [103,104]. Thus, a signiﬁ-
cant number of patients with orthopaedic implants developed
increased sensitivity to the alloy constituents [88,104]. Allergic
contact dermatitis is commonly triggered by Ni, Co and Cr
[105,106], and indeed sensitization to Ni by consumer products
and subsequent contact dermatitis resulted in the 1994 EU ‘‘Nickel
Directive’’ regulating consumer Ni exposure; although this remains
an issue [106]. In the UK, the prevalence of Cr and Co dermatitis in
patients was reported to be as high as 6% and 4%, respectively
[107]. The increased rate of haematopoietic malignancies reported
following metal-on-metal (MoM) joint replacements may be as a
consequence of metal particles activating the pre-malignant lym-
phoid tissue associated with osteoarthritic inﬂammatory changes
[108].
Critically, metal ions have been shown to exert a direct cyto-
toxic effect on peri-implant cells [92]. Ni, Al, Fe and, especially,
Co and V, were demonstrated to be toxic, reducing proliferation
and viability, and inducing alterations in cell morphology of peri-
implant cells at concentrations found in vivo in patients with joint
arthroplasties [92]. V cytotoxicity and mitogenicity were also
shown to lead to morphological neoplastic transformation
in vitro [109]. A signiﬁcant reduction of mouse ﬁbroblast and
osteoblast growth rates was found in the presence of V and Al
in vitro, with the combination being almost synergistic at produc-
ing cytotoxicity [110]. The authors also demonstrated the wear
particles from Ti–6Al–4V alloys exhibited a similar cytotoxic effect
in vitro. Al preconditioning of osteoblasts in vitro has been shown
to affect osteocalcin production in a dose-dependent manner
[111]. At sub-lethal doses of V elicited gross delayed cytotoxicity,
Ti and Al produced suppression of osteocalcin deposition and
matrix mineralization, while Co–Cr–Mo alloy had little effect
[112]. Soluble Ti and V encouraged superoxide anions release by
the neutrophils in vitro [113] and metal ions have been implicated
in enhanced macrophage resorptive function, osteoclast differenti-
ation and osteoclast-mediated surface corrosion [114–116]. Subse-
quent metal ion release could potentially trigger osteolysis,
altering the bone remodelling equilibrium and ultimately precipi-
tating bone loss and prosthetic loosening [88].
Bearing surfaces can inﬂuence the bone–implant interface
through the wear particles released. Co–Cr alloys wear particles
were linked to cytotoxicity, non-speciﬁc inﬂammatory reactions,
adverse macrophage responses, lymphocyte-dominated immuno-
logical hypersensitivity reactions (i.e. aseptic lymphocyte-
dominated vasculitis-associated lesions – ALVAL), and pseudo tumour
formation [108,114,117–121]. The type of adverse reaction and the
amount of induced cytotoxicity most likely depend on a combina-
tion of the nature of a material subjected to wear and individual
patient factors modulating the responses. Locally generated cyto-
kines trigger an intense recruitment and differentiation of osteo-
clast precursors [88,122]. These harmful reactions disrupt the
stable bone–implant interface, eventually resulting in osteolysis
and aseptic loosening, compromising implant functioning and sur-
vivorship. This remains a signiﬁcant orthopaedic issue, and cur-
rently aseptic loosening accounts for 40% and 32% of all total hip
and knee joint replacements, respectively [2], although the mech-
anism of the majority of these cases is commonly attributed to
polyethylene wear. However, clinical revision rate of MoM hip
replacements was observed to be 6.1% in females at 5 years [123].
Thus, whilst many of the metal materials that are considered
biocompatible are usually well tolerated, these materials are not
inert, and consequently, Ni-free stainless steels and Co–Cr alloys,
and V- and Al-free Ti alloys, are in development in an attempt to
balance biological incompatibility together with the practical need
for metals [31,34]. This balance is currently superior in Ti and Co–
Cr alloys [8].opaedic perspective on osseointegration of metals. Acta Biomater (2014),
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The surface energy is an excess free energy per unit area created
when a surface is established. The surface energy of a material can
be calculated from its wettability with water and subsequent mea-
surement of contact angles made by the water drops [124], with
high contact angles indicating hydrophobicity, and low angles indi-
cating hydrophilicity. This energy increases with increasing rough-
ness in transition metals, i.e. Ti [124], and is of importance as
material surface energy impacts on cell function.
The propensity and strength of in vitro cellular adhesion to
metal surfaces appears to be directly proportional to the surface
energy and hydrophilicity [125,126]. Hydrophilic rough Ti surfaces
were able to induce more osteoblast differentiation and release of
local growth factors in vitro, although cell proliferation was
impaired [127]. Controlling surface roughness while increasing
the wettability in vitro resulted in reduced cell numbers and
enhanced osteoblast differentiation [128], whilst in vivo experi-
ments demonstrated that increased wettability of implant surfaces
resulted in better initial bone apposition and bone–implant contact
[129]. Hydrophilic surfaces aid cell adhesion through adsorption of
matrix proteins such as ﬁbronectin and collagen [43,124]. Surface
hydrophilicity and protein adsorption decrease with extended
storage time – a phenomenon known as titanium-speciﬁc biologi-
cal ageing [130], which is believed to be linked to increasing hydro-
carbon surface contamination [126]. Alternatively, increased
bioactivity of the hydrophilic TiO2 layer could be related to the sur-
face basic and acidic hydroxyl groups [49], which appear to modify
the strength of cell surface integrin binding to ﬁbronectin-coated
surfaces in vitro [131]. Hydrophilic surfaces are able to adsorb
the proteins in a more ﬂexible conformation in vitro, permitting
their reorganization by the adhering cells [125], and improved
adhesion and spread of cells [132]. Conversely, Roach et al. found
that in vitro ﬁbrinogen-binding afﬁnity is stronger on hydrophobic
surfaces [39], and that the secondary structure of the proteins
adsorbed onto hydrophobic surfaces was less organized [39]. Fur-
thermore, lower surface energies were shown to achieve greater
ﬁbronectin adsorption and greater ﬁbronectin-mediated cell pro-
liferation in vitro [133]. These inconsistencies may be explained
by either the variation within experimental methods, or by the fact
that exceptionally high surface wettability is inhibitory to stable
protein adsorption, cell adhesion and proliferation [124].
Chemical modiﬁcations can alter surface wettability and rough-
ness [60,124]. Thus, surface energy, chemical composition and
topography of Ti surfaces all exert complex physicochemical inﬂu-
ences on cell function, integrin expression and VEGF production
in vitro [134]; a view further supported by the work of Aita et al.
[126] and Lamolle et al. [61]. Sommerfeld et al. indicated that
the relationship between nano-structure, surface energy and pro-
tein adsorption was not linear [135]. Exposure to UV light rendered
hydrophobic surfaces superhydrophilic (photofunctionalization).
This conversion to wettability was reversed by storage of materials
in the dark or exposure to the atmosphere [136]. UV photofunc-
tionalization of Ti surfaces enhances protein adsorption, osteoblast
attachment, proliferation and phenotype expression in vitro, and
implant ﬁxation in vivo [126]. Hence, UV treated surfaces stimu-
lated simultaneous osteoblast proliferation and differentiation,
thus accelerating bone formation without compromising bone
mass. These ﬁndings highlight the controversies in understanding
the potential role of surface energy in osseointegration. Clinically,
storage, sterilization methods and exposure of implants to air prior
to implantation are thus important considerations. However,
implant UV treatment pre-implantation to enhance osseointegra-
tion [126] and to overcome the phenomenon of biological ageing
[137] is appealing. Indeed, this strategy has been tested clinically,
with enhanced achievement of stability in photofunctionalized
implants leading to faster loading protocols of oral implants [138].Please cite this article in press as: Goriainov V et al. Bone and metal: An orth
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The phenomenon of shaping cell morphology by the physical
environment is known as surface guidance [139]. Osteoblast
adhesion to implant surface, proliferation and differentiation are
signiﬁcantly inﬂuenced by surface topography [44]. The topo-
graphical modiﬁcations can be introduced with additive (i.e. coat-
ings) and subtractive methods (i.e. etching), which lead to overall
enlargement of the surface area [42,140], while potentially altering
surface chemical composition and energy [42,43,140]. The advan-
tages of topographical stimulation of lineage-speciﬁc differentia-
tion are its stability and durability, relative ease of manufacture
and avoidance of highly regulated bioactive substances [41,141].
Moreover, the advantage of nanotopography is the high surface-
to-volume ratio afforded by nanotopography [142]. Surface topog-
raphy is deﬁned by surface orientation and roughness [140], and is
characterized by a succession of peaks and valleys [43]. To date, no
substantial evidence has been presented on surface orientation
affecting implant osseointegration, once the effect of roughness is
controlled [140]. In contrast, surface roughness is crucial for bioen-
gineering and is dependent on [143,124]: (i) macro-roughness, (ii)
micro-roughness, (iii) ultra-roughness, (iv) submicron roughness
and (v) nano-roughness.
Distinct roughness levels result in discrete effects on living tis-
sues [143]. On a three-dimensional (3-D) areal scale, rough sur-
faces were deﬁned as the average height deviation (Sa) of >2 lm,
moderately rough surfaces Sa of 1–2 lm, minimally rough surfaces
Sa of 0.5–1 lm and smooth surfaces Sa < 0.5 lm [144].
Moderate surface roughness has been associated with stronger
bone responses in vitro and in vivo [43,145], and a potential opti-
mal range of roughness for implant osseointegration [42]. Ronold
et al. demonstrated an increase in the interface tensile strength
with increasing roughness up to Sa of 3.9, beyond which the corre-
lation reversed [42]. This effect is not related to the increased
metal ion release from the surface-enlarged implants [145]. On a
cellular level, moderate roughness may be more optimal for cell
attachment, with excessively rough surfaces leaving unduly long
distances between their peaks that cells perceive them as ﬂat,
and ﬂat surfaces causing excessive cells ﬂattening and compromis-
ing their nutrition [140]. The changes in the adhesion spread of the
cells lead to morphological transformations, and will be discussed
later [41,146]. On a mechanical level, exceptionally rough surfaces
only achieve contact at the peaks, while ﬂat surfaces do not offer
sufﬁcient frictional resistance to displacement. Critically, in vivo
bone requires spaces of at least 50 lm for successful turnover
and remodelling [147], resulting in the area of functional osseoin-
tegration being smaller than the theoretical surface area on the
surfaces with tightly spaced peaks.
The effect of macro-roughness is largely mechanical, with the
irregularities mechanically strengthening the implant anchorage,
but being too large to be recognized by cells [124]. In contrast,
micro- and ultra-topographies appear to inﬂuence osteogenesis
through alterations in mesenchymal stem cell behaviour [143].
Existing machining processes, surface characterization tech-
niques and measuring equipment give rise to quite a wide range
of reported surface roughness characteristics [41,140]. The data
presented often measure roughness as either Sa or Ra (graphically
explained in Fig. 1), making comparisons of height parameters dif-
ﬁcult. Equally, a spatial or hybrid parameter needs to supplement a
height parameter for an adequate understanding of surface topog-
raphy [43,140,144]. As a consequence, controversial outcomes are
reported for micro-rough surfaces. Moderately rough Ti surfaces
(Sa = 1.2 lm, roughness being well deﬁned with additional param-
eters) in vitro inﬂuenced osteoblast morphology, inhibited cell pro-
liferation, and enhanced ALP activity, osteocalcin expression (in
synergy with 1a,25(OH)2D3) and local production of TGF-b1 and
prostaglandin E2 (PGE2), when compared to smoother surfacesopaedic perspective on osseointegration of metals. Acta Biomater (2014),
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to the surface energy. Generation of TGF-b1 and PGE2 molecules
further enhances the osteogenic microenvironment. Similarly, cell
proliferation was inhibited and cell differentiation promoted by
the rough surfaces with Ra > 4 lm in vitro [148]. In this study,
despite enhancement in osteocalcin, TGF-b1 and PGE2 secretion,
ALP expression was reduced by the rough surfaces in cells of all
maturity levels. Rough Ti–6Al–4V surfaces with Ra > 2.5 lm
reduced proliferation, induced osteogenic differentiation and
increased expression of b-actin and ERK2 genes in vitro [149].
b-actin is involved in cytoplasmic streaming during locomotion
or cell shape alterations, while ERK2 (p42 mitogen-activated pro-
tein kinase – MAPK) regulates proliferation and differentiation.
Actin cytoskeleton interacts with MAPK [150], which will be dis-
cussed in more detail later. The in vitro effect of rough microsurfac-
es and 1a,25(OH)2D3 on osteoblast differentiation was found to be
synergistic and dose-dependent [148,151,152]. Therefore, the gen-
eral tendency is for the rougher surfaces to suppress proliferation,
while stimulating differentiation. On the other hand, Ti alloy sur-
faces with Ra = 0.87 lm were found to promote cell attachment
and proliferation more effectively than Ra = 0.32 lm, possibly as
a result of a 10-fold increase of ﬁbronectin adsorption on the
rougher surfaces in vitro [153]. Anselme found that cells exhibited
reduced proliferation and differentiation on rougher (Ra > 2 lm)
and less organized surfaces, with the highest cell numbers
observed on the surface with Ra = 0.16 lm [44]. These disagree-
ments may be due to incomplete surface characterization, or the
fact that the osteogenic response is dependent on the maturation
state of the cells [148]. Lohmann et al. found that osteogenic differ-
entiation stimulated by the rough surfaces is more pronounced in
less mature cells [148]. In vivo studies reveal higher interface
strength achieved by rougher surfaces [154]. Wennerberg and
Albrektsson concluded that on the basis of evidence from in vivo
and clinical studies, there is an indication that microtopography
enhances bone responses, leading to stronger osseointegration
[140].
Nanotopography is possessed by all material surfaces, and is
subtly different to nanostructure, which incorporates nanotexture
and nanopattern [43]. Nanotopographic surface modiﬁcations hold
great promise [124,140,141]. Bone features possess an array of
magnitudes [19]. Mineral crystals and collagen ﬁbres are measuredFig. 1. Graphical comparison of Sa and Ra m
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of organization [41]. Mineralized osteoid contains an intricate
blend of ﬁbres, pits and protrusions [155]. Therefore, nanotopogra-
phies can be designed to mimic these nanofeatures, stimulating an
appropriate response. The nanotopography manufacturing process
allows for enhanced control over the surface [41], in turn, permit-
ting the study of the effect of texture and its organization. The
effect of nanotopography, to date, appears to be unaffected by
the surface material [156], and was shown to contribute to osteo-
genic differentiation by upregulating the transcription factor
Runx2 phosphorylation [157]. Human mesenchymal stem cells
(hMSCs) cultured on 15 nm nanotopographical cues were most
optimally spread and cytoskeletally organized, and expressed the
highest levels of osteocalcin and osteopontin, compared to 55
and 100 nm cues [156]. The same group indicated that nanostruc-
turing of surfaces with islands of 33 nm elicited more speciﬁc inte-
grin and ERK gene up-regulation than 362 nm deep pits or
exposure to dexamethasone [158]. Genetic modulation by nano-
cues appears more selective than by dexamethasone. Activation
of pathways related to adhesion and cytoskeleton agrees with a
mechanism involved in focal adhesion assembly and signal trans-
duction [150]. Rho regulates this process by triggering the aggrega-
tion of integrins at focal adhesions [159], which initiate signal
transduction of the stimuli from the ECM to the nucleus via
dynamic intracellular protein interactions, resulting in nuclear
deformation and modulation of genetic activity [160]. Rho GTPase
activation in combination with cytoskeletal tension induced by
actin ﬁbres was found essential for in vitro commitment of MSCs
to osteogenic lineage [146]. In vitro and in vivo investigation of
Ti surfaces with 20, 30 and 50 nm nanopores showed upregulation
of Runx2 transcription factor, ALP and osteocalcin expression, and
the highest bone–implant contact and pull-out strength on the
largest nanopores [161]. Zhang et al. revealed that, compared to
10 nm wide cues and planar controls, nanodimensional cues of
30 nm triggered ampliﬁed cell adhesion and expression of Runx2,
ALP, osteopontin and osteocalcin genes in vitro [162]. The surfaces
with larger nanocues were also shown to be more hydrophilic
[162]. Oh et al. observed that TiO2 nanotube diameters of 70 and
100 nm, and not 30 nm, caused signiﬁcant cell elongation, ﬁlopodia
formation and increased cytoskeletal stress, resulting in preferen-
tial osteogenic differentiation in vitro [142].easurements of the surface roughness.
opaedic perspective on osseointegration of metals. Acta Biomater (2014),
Fig. 2. Retrieved Co–Cr acetabular cup porous surface of cast beads demonstrates
successful bone on- and in-growth.
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stimulation of hMSC is potentially related to the formation of cell
adhesions and the resultant alteration of intracellular tension
[41,160]. Nanoscale cues stimulate a ﬁlopodia-mediated response
by cells, resulting in contact guidance and change in cell morphol-
ogy on features as little as 10 nm [163]. Adherent and spread MSCs
exhibited more prominent stress ﬁbres and were more likely to
undergo osteogenic differentiation compared to more rounded
cells [146]. On 90 and 55 nm high islands, in vitro cytoskeletal for-
mation and organization were more distinct than on planar sur-
faces [164]. On 10 and 25 lm wide grooves cells assumed
polarized non-spread morphology and displayed downregulation
of Rho and a-actin expression, leading to reduced cellular tension
and reduced cellular signaling, while stress ﬁbres and adhesion for-
mation on 100 lm grooves appeared similar to planar controls, as
an increased inter-ridge area allowed the cells to spread out and
assume osteo-speciﬁc function [160]. Nanotopographies have also
been shown to be disruptive to focal osteoblast adhesion formation
in vitro [155,157], being especially pronounced on 120 nm wide
nanopit topographies, when compared to nanocraters and
nanoislands. Intriguingly, despite a general downregulation ofFig. 3. (a) Retrieved large diameter Co–Cr femoral head and monobloc Co–Cr acetabular
wear scars (purple) at 30 to the pole.
Please cite this article in press as: Goriainov V et al. Bone and metal: An orth
http://dx.doi.org/10.1016/j.actbio.2014.06.004focal adhesion formation by different nanocues, osteoblasts
cultured on nanopits demonstrated a reduction in fundamental
signaling pathways, while on nanocraters and nanoislands –
enhanced expression of genes essential for osteogenesis. These
ﬁndings indicate the complex relationship between nanocues, cell
adhesions, cytoskeletal tension and cell differentiation.
In contrast, nanopattern pits 120 nm wide and 100 nm deep
were found to be essential for osteogenic differentiation in the
absence of other osteogenic factors. Compared to planar controls,
square ordered (SQ) and completely random patterns, disordered
square pits (displacement by up to 50 nm on either axis from their
square position (DSQ50)) signiﬁcantly augmented dense mesen-
chymal stem cell aggregation into bone nodules with elevated lev-
els of osteocalcin, osteopontin and bone osteoid formation [41].
Subsequently, McMurray et al. demonstrated in vitro retention of
skeletal stem cell markers at 8 weeks in cells cultured on SQ sur-
faces, while DSQ50 again elicited osteogenic cell differentiation
[165]. Increased expression of osteocalcin and osteopontin after
21 days of cultures on nanotopographical surfaces in vitro [158]
correlated with osteoblast differentiation timelines described by
Lian and Stein [12]. Recently, nanocues were demonstrated to
induce the activation of canonical signaling pathways, possibly
indicating earlier stimulation of osteogenic differentiation [158].
Interestingly, nanotopographies did not inhibit endothelial differ-
entiation [158] essential for neovascularization in de novo bone
synthesis.
Cell adhesion to implant surfaces is mediated by extracellular
matrix proteins [124]. Greater surface microtopography, and
consequently greater surface area for ﬁbrinogen adsorption, leads
to enhanced platelet adhesion and activation, and potential
up-regulation of osteogenic reactions in vitro [166,153]. Complex
implant surfaces are more amenable to ﬁbrin attachment, thus
establishing the temporary osteoconductive matrix [10]. The asso-
ciation between surface texture, osteoconductive matrix formation
and subsequent recruitment of osteogenic cells may be an impor-
tant consideration in understanding the process of contact osteo-
genesis, de novo bone formation and in vivo implant integration.
Nanotopography is currently receiving signiﬁcant interest as a
cue that can be patterned onto load-bearing devices for in vivo
application.
2.2.5. Implant porosity
Implant porosity is essential for in vivo vascular formation, pro-
liferation of mesenchymal cells and ultimately osteogenesis [167],
and is key in facilitating successful osseointegration, as illustratedcup used in MoM bearing. (b) The RedLux height map of the head and cup, showing
opaedic perspective on osseointegration of metals. Acta Biomater (2014),
Fig. 3 (continued)
8 V. Goriainov et al. / Acta Biomaterialia xxx (2014) xxx–xxxin Fig. 2. Trabecular metal (TM) is an example of a highly porous
material, made of elemental tantalum, in clinical use [168].
Similarly to Ti, tantalum forms a passive oxide layer [168], which,
on exposure to bodily ﬂuids, adsorbs hydroxyl groups combining
with calcium and phosphate to form apatite nucleation [169].
The 3-D structure of TM provides a continuous regular lattice of
struts, allowing for interconnecting pores of consistent size and
an overall porosity of 80% [170], enabling rapid bone ingrowth
and enhanced interface shear strength in vivo [171]. Although
the Young’s modulus of tantalum is reasonably high, an inherent
degree of ﬂexibility in the structure of TM enables its stiffness to
approach that of trabecular bone, thus facilitating physiologic loadFig. 4. (a) Retrieved large diameter Co–Cr femoral head taper, trunnion and the cemented
cement interface. (b) The RedLux height map of the taper showing wear scars (purple) i
trunnion showing polar end damage.
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only minimally less stable than cemented implants, even in the
presence of signiﬁcant bone defects ﬁlled with bone graft [172],
resulting in, to date, good clinical implant survival [173,174],
although long-term results are awaited given this is a new technol-
ogy. Critically, there remains a paucity of evidence on the exact
surface characterization of tantalum after fabrication.
3. Case report
The main perceived advantage, leading to the renewed interest
in MoM bearing surfaces in hip arthroplasty in 1990s, was theirstem. Wear-assisted corrosion damage is seen on the stem, likely disrupting stem–
n sub-polar regions where the trunnion engages. (c) The RedLux height map of the
opaedic perspective on osseointegration of metals. Acta Biomater (2014),
Fig. 4 (continued)
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Other advantages included bone stock conservation in resurfacings
and greater stability due to the use of larger head sizes [97,175].
This was supported by promising mid-term clinical results [176];
however, recent evidence has demonstrated signiﬁcant failure,
local adverse reactions and systemic effects [2,97,177], triggered
by metal debris generated from bearing surfaces or tapered junc-
tions [97]. Asymptomatic MoM bearing hips may be associated
with signiﬁcantly elevated metal ion levels [97], and thus current
clinical advice for patients with MoM implants in situ is to be
reviewed yearly, with blood metal ion levels and hip magnetic res-
onance imaging (MRI) investigations [177].
A 64-year-old female had an uncomplicated primary hybrid
MoM THR in 2004, with satisfactory radiographic examination. In
2010 the patient developed signiﬁcant groin pain and radiographic
assessment revealed evidence of acetabular loosening in zones 1, 2
and 3, and calcar bone resorption. Interestingly, inﬂammatory
markers were normal and blood Co and Cr levels were 162 and
118 nmol l1, respectively, and while an MRI scan showed moder-
ate ﬂuid collection, hip joint aspiration revealed no evidence of
infection (Co and Cr levels of 2510 nmol l1 (148 ppb) and
1780 nmol l1 (93 ppb)).
The patient underwent revision surgery using a ceramic-on-
polyethylene bearing couple in 2012. Peri-operative cavitaryPlease cite this article in press as: Goriainov V et al. Bone and metal: An orth
http://dx.doi.org/10.1016/j.actbio.2014.06.004acetabular bone defects, calcar erosions, brown joint ﬂuid and tissue
metallosis were seen at surgery. Histological examination of peri-
operative samples revealed metallosis and moderate ALVAL. Post-
operatively, the symptoms improved, and at 12 months the Co and
Cr levels returned to normal (19 nmol l1 (1 ppb) and 16 nmol l1
(0.8 ppb). Non-contact 3-D metrological investigations of the
retrieved implant surfaces were performed using an artiﬁcial hip
joint proﬁler (RedLux, Southampton, UK). The analysis showed char-
acteristic wear scars on the head and cup (Fig. 3a and b), and taper
and trunnion (Fig. 4a–c), indicating the origin of wear particles.
Mechanically assisted crevice corrosion at the head/neck junction
was previously shown to be signiﬁcant in MoM THR failures [98],
generating wear particles that might be more harmful to the local
soft tissues than those from the bearing surfaces [99].While the vol-
umetricwear decreases at the bearing surfaceswith their increasing
diameter, the metal ion release from the taper junction increases
[98], the increased torque from larger bearing surfaces possibly con-
tributing to the toggling and wear-assisted changes at the taper
junction. The toggling created peaks in load at the open distal end
of the taper junction, causingmore pronounceddamage, but the tor-
que also triggered mechanically assisted changes more distally at
the stem, generating a high metal ion and particle load. Therefore,
a combination of corrosion andwear debris release discussed above
resulted in the failure of primary THR requiring revision.opaedic perspective on osseointegration of metals. Acta Biomater (2014),
12 V. Goriainov et al. / Acta Biomaterialia xxx (2014) xxx–xxx4. Conclusion
In this paper we have reviewed aspects of osseointegration rel-
evant to the orthopaedic practice (summarized in Table 1). It is
important to note that only 33–62% bone–implant contact is
achieved by modern titanium implants with commercially avail-
able surface treatments at 3–6 months [178], indicating opportuni-
ties for improvements in osseointegration through further
research. Osseointegration is a complex process involving a num-
ber of distinct mechanisms affected by the implant bulk properties
and surface characteristics. However, despite signiﬁcant invest-
ments into bioengineering research, developments remain limited
often as a consequence of non-standardization of approaches
across the industry and ﬁeld. The biological ageing of titanium
facilitates the understanding of variation in initial host reactions
post-implantation, and may aid in greater translation to wide clin-
ical market application in orthopaedic prosthetics. In modern
orthopaedic implant design, the choice of materials and their bulk
properties, together with surface modiﬁcations including wettabil-
ity, roughness, HA coating and porosity, have been carefully con-
sidered and implemented to result in improved clinical efﬁcacy.Acknowledgements
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